Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL ALBENDAZOLE INDUSTRY
2.1 Summary about Albendazole Industry
2.2 Albendazole Market Trends
2.2.1 Albendazole Production & Consumption Trends
2.2.2 Albendazole Demand Structure Trends
2.3 Albendazole Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Capsule
4.2.2 Tablet
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Pinworm Infection Treatment
4.3.2 Ascaris Infection Treatment
4.3.3 Other Parasitic Infections Treatment
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Capsule
5.2.2 Tablet
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Pinworm Infection Treatment
5.3.2 Ascaris Infection Treatment
5.3.3 Other Parasitic Infections Treatment
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Capsule
6.2.2 Tablet
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Pinworm Infection Treatment
6.3.2 Ascaris Infection Treatment
6.3.3 Other Parasitic Infections Treatment
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Capsule
7.2.2 Tablet
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Pinworm Infection Treatment
7.3.2 Ascaris Infection Treatment
7.3.3 Other Parasitic Infections Treatment
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Capsule
8.2.2 Tablet
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Pinworm Infection Treatment
8.3.2 Ascaris Infection Treatment
8.3.3 Other Parasitic Infections Treatment
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Capsule
9.2.2 Tablet
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Pinworm Infection Treatment
9.3.2 Ascaris Infection Treatment
9.3.3 Other Parasitic Infections Treatment
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 CHANGZHOU YABANG
10.1.2 GlaxoSmithKline
10.1.3 Huazhong Pharmaceutical
10.1.4 Hubei Zhongjia-chem Pharmaceutical
10.1.5 HUBEI KEYI
10.1.6 Sequent Scientifi
10.1.7 Lasa Laboratory Pvt Ltd
10.1.8 K.A.Malle Pharmaceuticals
10.1.9 Supharma Chem
10.1.10 Salius Pharma
10.1.11 Fredun Pharmaceuticals Ltd
10.1.12 Ashish life Science Pvt. Ltd.
10.1.13 AdvacarePharma
10.1.14 MANAV DRUGS
10.1.15 Leo Bio-Care Pvt.
10.2 Albendazole Sales Date of Major Players (2017-2020e)
10.2.1 CHANGZHOU YABANG
10.2.2 GlaxoSmithKline
10.2.3 Huazhong Pharmaceutical
10.2.4 Hubei Zhongjia-chem Pharmaceutical
10.2.5 HUBEI KEYI
10.2.6 Sequent Scientifi
10.2.7 Lasa Laboratory Pvt Ltd
10.2.8 K.A.Malle Pharmaceuticals
10.2.9 Supharma Chem
10.2.10 Salius Pharma
10.2.11 Fredun Pharmaceuticals Ltd
10.2.12 Ashish life Science Pvt. Ltd.
10.2.13 AdvacarePharma
10.2.14 MANAV DRUGS
10.2.15 Leo Bio-Care Pvt.
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
